Document Detail


Expression of matrix metalloproteinase-2 and -9 and of tissue inhibitor of matrix metalloproteinase-1 in liver regeneration from oval cells in rat.
MedLine Citation:
PMID:  18678246     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Oval cells participate in liver regeneration when hepatocyte replication is impaired. These precursor cells proliferate in periportal regions and organize in ductules. They are surrounded by a basement membrane, the degradation of which by matrix metalloproteinases (MMP) might trigger their terminal differentiation into hepatocytes. We studied the expression of MMP-2 and MMP-9 and that of one of their tissue inhibitors (TIMP-1) in a model of hepatic regeneration from precursor cells. Regeneration was induced by treating rats with 2-acetylaminofluorene followed by partial hepatectomy. MMP-2 and MMP-9 hepatic expression paralleled oval cell number with a peak at day 9-14 after hepatectomy. They were mainly detected in oval cells. TIMP-1 mRNA and oncostatin M receptor mRNA, a major regulator of TIMP-1 synthesis, markedly increased from day 1 after surgery until day 9 and then declined; they were mainly detected in interlobular bile duct cells and oval cells until day 14. In agreement with the in vivo data, the WB-F344 liver precursor cell line expressed MMP-2 and MMP-9, as well as TIMP-1 and oncostatin M receptor. These data suggest that (a) early increased TIMP-1 synthesis by biliary and oval cells favors basement membrane deposition around proliferating ductular structures through MMP inhibition, (b) delayed increased MMP expression, concomitant to decreased TIMP-1 synthesis, leads to basement membrane degradation, preceding oval cell differentiation, (c) the oncostatin M pathway might play a major role in increased TIMP-1 synthesis.
Authors:
T Pham Van; D Couchie; N Martin-Garcia; Y Laperche; E S Zafrani; P Mavier
Related Documents :
20818746 - Stable overexpression of pregnane x receptor in hepg2 cells increases its potential for...
20831856 - γ-glutamyl transpeptidase is a heavily n-glycosylated heterodimer in hepg2 cells.
18220566 - Cell lines: a tool for in vitro drug metabolism studies.
2990576 - Endothelial binding of transferrin in fractionated liver cell suspensions.
25251136 - Rutin upregulates neurotrophic factors resulting in attenuation of ethanol-induced oxid...
19551446 - Comparison of gene-transfer efficiency in human embryonic stem cells.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2008-07-16
Journal Detail:
Title:  Matrix biology : journal of the International Society for Matrix Biology     Volume:  27     ISSN:  0945-053X     ISO Abbreviation:  Matrix Biol.     Publication Date:  2008 Oct 
Date Detail:
Created Date:  2008-12-01     Completed Date:  2009-06-11     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9432592     Medline TA:  Matrix Biol     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  674-81     Citation Subset:  IM    
Affiliation:
INSERM U841, Université Paris 12, AP-HP, Groupe Hospitalier Henri Mondor-Albert Chenevier, Département de Pathologie, Créteil, F-94000 France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Cells, Cultured
Gene Expression Regulation, Enzymologic*
Hepatocytes / enzymology
In Situ Hybridization
Liver / cytology*,  enzymology*
Liver Regeneration* / genetics
Male
Matrix Metalloproteinase 2 / genetics,  metabolism*
Matrix Metalloproteinase 9 / genetics,  metabolism*
Oncostatin M / genetics,  metabolism
Rats
Rats, Inbred F344
Receptors, Oncostatin M / genetics,  metabolism
Tissue Inhibitor of Metalloproteinase-1 / genetics,  metabolism*
Chemical
Reg. No./Substance:
0/Receptors, Oncostatin M; 0/Tissue Inhibitor of Metalloproteinase-1; 106956-32-5/Oncostatin M; EC 3.4.24.24/Matrix Metalloproteinase 2; EC 3.4.24.35/Matrix Metalloproteinase 9

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Comparison of two twin-screw extruders for continuous granulation.
Next Document:  T-cells behaving badly: structural insights into alloreactivity and autoimmunity.